Adam Farber is both the global leader of the Health Care practice and a core member of the Operations practice at Boston Consulting Group.

Since he joined BCG in 1998, Adam's client work has covered multiple sectors in health care, including biopharma and medtech, payers, providers, and global health.

Adam's client work has ranged from strategy definition to business model/organization changes, growth and innovation, operations/supply chain transformation, and applying digital and analytics to drive business acceleration.

Adam has authored articles for the industry journal Pharmaceutical Executive, and he has contributed a chapter to the BCG book, Own the Future: 50 Ways to Win from The Boston Consulting Group.

Prior to joining BCG, Adam worked at the management consultancy Lochridge & Company.

AREAS OF EXPERTISE

  • Global Leader, Health Care practice
  • Health care, focusing on biopharma
  • Health care payers, providers, medtech, and foundations
  • Corporate and divisional strategy development
  • Analytics strategy for business acceleration
  • Operating model/organization design and implementation
  • Supply chain strategy and plant network optimization
  • Development and implementation of operational excellence/Lean transformation
  • PMI
  • Private equity due diligence

EDUCATION

  • MBA, with concentration in finance, The Wharton School of the University of Pennsylvania
  • BA, magna cum laude, Dartmouth College

Publications and Videos

three-paths-future-rectangle-tcm9-249051.jpg

Three Paths to the Future

Three strategies for fighting the coronavirus and restarting economies have emerged. The most popular one is the most unstable.
critical-priorities-pharma-medtech-response-covid-19-rectangle-tcm9-240805.jpg

Critical Priorities for Pharma and Medtech in Response to COVID-19

In their response to COVID-19, pharma and medtech companies have been true to their purpose. They now face questions that go beyond addressing the virus itself.
how-three-leaders-2880x1620-tcm9-189278.jpg

How Three Leaders Are Building Their Teams and Boosting Results

Traditional leadership models are out of date. It’s time to do things differently.
KW-Two-Speeds_artillustr_large_tcm9-114282.png

Rethinking Operations for a Two-Speed World

To succeed in both high- and low-growth markets, companies must rethink every aspect of their operations, BCG contends in a report published jointly with Knowledge@Wharton.
adam farber 2.png

Lean Comes to Pharma

Lean practices have much to offer biopharma—but realizing those benefits hinges on proper implementation. The keys are an incremental approach and engagement of frontline staff.
2009-lean-in-a-downturn-1116x626-tcm9-125695.jpg

The Downturn: Thinking Smaller and Smarter

In a downturn, well-executed lean programs can cut production cycle times and quality costs by half—and quick wins can deliver much of these savings.
2008-getting-lean-1116x626-tcm9-127888.jpg

Seven Steps to a Leaner Organization

Getting smaller requires big thinking. To drive real organizational change, lean programs must be ambitious and far-reaching.
Deep Expertise, Broad Experience